Literature DB >> 33738050

Degradation of Janus Kinase for Potential Application in Immune Response Therapeutics.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 33738050      PMCID： PMC7957942          DOI： 10.1021/acsmedchemlett.1c00058

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Delgocitinib: First Approval.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 2.  Emerging systemic drugs in the treatment of plaque psoriasis.

Authors:  Esther A Balogh; Arjun M Bashyam; Rima I Ghamrawi; Steven R Feldman
Journal:  Expert Opin Emerg Drugs       Date:  2020-03-31       Impact factor: 4.191

Review 3.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

Review 4.  Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma.

Authors:  Mark Zak; Hart S Dengler; Naomi S Rajapaksa
Journal:  Bioorg Med Chem Lett       Date:  2019-09-03       Impact factor: 2.823

Review 5.  Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis.

Authors:  Novin Nezamololama; Erika L Crowley; Melinda J Gooderham; Kim Papp
Journal:  Expert Opin Investig Drugs       Date:  2020-09-30       Impact factor: 6.206
  5 in total
  2 in total

Review 1.  Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.

Authors:  Maria Teresa Bochicchio; Valeria Di Battista; Pietro Poggio; Giovanna Carrà; Alessandro Morotti; Mara Brancaccio; Alessandro Lucchesi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 2.  JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

Authors:  Charlotte Ej Downes; Barbara J McClure; Daniel P McDougal; Susan L Heatley; John B Bruning; Daniel Thomas; David T Yeung; Deborah L White
Journal:  Front Cell Dev Biol       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.